Terminalia chebula (haritaki), a dried fruit prized in Ayurvedic medicine, is a dietary supplement used to ease joint discomfort, lower uric acid and, as a mouth rinse, reduce plaque and gum inflammation. Gum benefits from rinses have the strongest human evidence; joint and uric acid benefits rest on single small, largely maker-sponsored trials. Extracts were well tolerated for up to six months; long-term health outcomes remain unproven. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Serum uric acid | 3.5–5.5 mg/dL | Tracks urate lowering |
| hsCRP | Below 1.0 mg/L | Tracks inflammation |
| Fasting glucose | 75–90 mg/dL | Detects additive glucose lowering |
| HbA1c | 4.8–5.4% | Tracks longer-term glucose control |
| LDL cholesterol | Below 100 mg/dL | Checks lipid effect |
| Ferritin | 50–150 ng/mL | Detects iron-store decline |
| ALT | Below 25 U/L | Screens for liver strain |
| eGFR | Above 90 mL/min/1.73 m² | Checks kidney clearance |
| Blood lead | Below 1 µg/dL | Screens for product contamination |
Cadence: Baseline before starting; 4 weeks (uric acid, and glucose if on diabetes drugs); 12 weeks (full panel); then every 6–12 months while use continues